Literature DB >> 6625350

Deposition pattern of inorganic particles at the alveolar level in the lungs of rats and mice.

A R Brody, M W Roe.   

Abstract

The early pathogenesis of particle-induced lung disease is likely to be determined in large part by the initial pattern of dust deposition at the alveolar level. We have studied the deposition pattern of 5 aerosolized dusts (chrysotile and crocidolite asbestos, fiber glass, alpha-quartz, and ash from Mt. St. Helens) in the lungs of rats. Mice were exposed to chrysotile asbestos. Quantitative electron microscopy was carried out on tissues fixed by vascular perfusion. Immediately after a brief exposure, significantly (p less than or equal to 0.01) greater numbers of particulates had deposited on alveolar duct bifurcations when compared with the number of particles on duct surfaces adjacent to the bifurcations. Few particles were counted at midpoints between bifurcations, and particles rarely were observed within alveoli. Our data show that regardless of mineral nature, shape, or concentration, inhaled particulates small enough to pass through the conducting airways are deposited primarily at alveolar duct bifurcations. We proposed that the alveolar deposition patterns observed are the result of air-flow characteristics that cause enhanced deposition of particles at alveolar duct bifurcations intersecting the flow. This is similar to deposition patterns that occur at bifurcations of conducting airways.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6625350     DOI: 10.1164/arrd.1983.128.4.724

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  25 in total

1.  Inhalation of chrysotile asbestos induces rapid cellular proliferation in small pulmonary vessels of mice and rats.

Authors:  P D McGavran; L B Moore; A R Brody
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

2.  Incorporation of tritiated thymidine by epithelial and interstitial cells in bronchiolar-alveolar regions of asbestos-exposed rats.

Authors:  A R Brody; L H Overby
Journal:  Am J Pathol       Date:  1989-01       Impact factor: 4.307

3.  Production of reactive oxygen metabolites induced by asbestos fibres in human polymorphonuclear leucocytes.

Authors:  M Hedenborg; M Klockars
Journal:  J Clin Pathol       Date:  1987-10       Impact factor: 3.411

Review 4.  Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos.

Authors:  Brooke T Mossman; Morton Lippmann; Thomas W Hesterberg; Karl T Kelsey; Aaron Barchowsky; James C Bonner
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

5.  Comparative effects of inhaled silica or synthetic graphite dusts on rat alveolar cells.

Authors:  R S Anderson; S M Thomson; L L Gutshall
Journal:  Arch Environ Contam Toxicol       Date:  1989-11       Impact factor: 2.804

6.  Fiber localization and its relationship to lung reaction in rats after chronic inhalation of chrysotile asbestos.

Authors:  K E Pinkerton; P C Pratt; A R Brody; J D Crapo
Journal:  Am J Pathol       Date:  1984-12       Impact factor: 4.307

7.  Up-regulated expression of transforming growth factor-alpha in the bronchiolar-alveolar duct regions of asbestos-exposed rats.

Authors:  J Y Liu; G F Morris; W H Lei; M Corti; A R Brody
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

Review 8.  Deposition and retention of inhaled fibres: effects on incidence of lung cancer and mesothelioma.

Authors:  M Lippmann
Journal:  Occup Environ Med       Date:  1994-12       Impact factor: 4.402

9.  Progressive lung cell reactions and extracellular matrix production after a brief exposure to asbestos.

Authors:  L Y Chang; L H Overby; A R Brody; J D Crapo
Journal:  Am J Pathol       Date:  1988-04       Impact factor: 4.307

Review 10.  Alveolar duct expansion greatly enhances aerosol deposition: a three-dimensional computational fluid dynamics study.

Authors:  C Darquenne; L Harrington; G K Prisk
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2009-06-13       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.